Chemical sensitivity screening test
AssigneeBryson Patents Inc.
InventorBryan Christopher Farnum
Life of this patent
Estimating the term…
Loading patent…
AssigneeBryson Patents Inc.
InventorBryan Christopher Farnum
Estimating the term…
The present document describes a screening composition comprising a marker compound, chosen from at least one of iodine, and fluorescein; eosin Y, erythrosine, ponceau S, calcein, a catalyst, chosen from at least one boron trioxide (B2O3), potassium (K), Gallium (III) oxide (Ga2O3), Nickel (II) oxide (NiO), Vanadium (V) oxide (V2O5), magnesium oxide (MgO), a bismuth oxide chosen from bismuth subcarbonate [Bi2O2(CO3)], bismuth chloride oxide (BiClO), and bismuth oxide (Bi2O3), cesium bromide (CsBr), lanthanum (III) oxide (La2O3), molybdenum (VI) oxide (MoO3), neodymium oxide (Nd2O3), Nickel (II) carbonate anhydrous (NiCO3); and a pigment, chosen from at least one of scandium (III) oxide (Sc2O3), Lead (IV) oxide (PbO2), Sulfur (S) powder, and Tungsten (VI) oxide (WO3), chromium (III) oxide (Cr2O3), copper (II) oxide (CuO), copper (I) oxide (Cu2O), iron (III) oxide (Fe2O3), lead (II) oxide (PbO). The document also describes method of using the same.
A screening composition comprising:
Dependencies are inferred from the claim text.